Vallon Pharmaceuticals, Inc. (NASDAQ:VLON – Get Rating) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totalling 90,700 shares, a drop of 59.6% from the March 15th total of 224,600 shares. Based on an average daily volume of 6,580,000 shares, the short-interest ratio is […]
Should You Buy or Sell Vallon Pharmaceuticals Stock? Get The Latest VLON Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.